Psyence Biomedical Ltd stock is traded at $2.94, with a volume of 33,847. It is down -7.55% in the last 24 hours and down -41.43% over the past month. Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.
Previous Close:
$3.18
Open:
$3.19
24h Volume:
33,847
Relative Volume:
0.51
Market Cap:
$11.21M
Revenue:
-
Net Income/Loss:
$1.52M
P/E Ratio:
-
EPS:
-$6.32
Net Cash Flow:
-$1.14M
1W Performance:
-11.18%
1M Performance:
-41.43%
6M Performance:
-50.42%
1Y Performance:
-81.28%
1-Day Range:
$0.00$0.00
1-Week Range:
$2.85$3.55
52-Week Range:
$1.92$18.62
Psyence Biomedical Ltd Stock (PBM) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS